旅行疫苗市場：類型（減毒疫苗、結合疫苗、DNA疫苗）、疾病（百白破、甲型肝炎、乙型肝炎）-俄烏衝突和高通脹-2023-2030年全球預測

全球旅行疫苗市場預計將在2023年大幅增長至82,670.1億美元，複合年增長率為10.04%，2030年將達到16,181.43百萬美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球旅行疫苗市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細資訊。

4.市場趨勢：全面了解俄羅斯-烏克蘭衝突和高通脹。

5.競爭評估和資訊：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.全球旅行疫苗市場規模及預測是多少？

2. 在預測期內，COVID-19 對全球旅行疫苗市場的影響有哪些障礙和影響？

3. 在預測期內，全球旅行疫苗市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球旅行疫苗市場的競爭策略是什麼？

5.全球旅行疫苗市場的技術趨勢和監管框架是什麼？

6. 全球旅行疫苗市場主要供應商的市場份額是多少？

7. 哪些形式和策略舉措被認為適合進入全球旅行疫苗市場？

目錄

第 1 章前言

第 2 章研究方法

第 3 章執行摘要

第 4 章市場概述

第 5 章市場洞察

• 市場動態
  • 促進因素
    • 國際旅遊日益受歡迎
    • 傳染病的傳播與聯合疫苗的開發
    • 近期對冷鏈倉儲基礎設施的投資和改進
  • 抑制因素
    • 遊客意識有限
  • 機會
    • 新疫苗技術的創新和進步
    • 政府和組織為免疫和疫苗開發提供的資金和努力
  • 課題
    • 疫苗處理和儲存問題
• 市場趨勢
• 新冠肺炎 (COVID-19) 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通脹的累積影響
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 監管框架
• 客戶定制

第 6 章旅行疫苗市場：按類型

• 減毒疫苗
• 結合疫苗
• DNA疫苗
• 非活性疫苗
• 重組載體疫苗
• 亞單位疫苗
• 類毒素疫苗

第 7 章旅行疫苗市場：按疾病分類

• DPT
• 甲型肝炎
• 乙型肝炎
• 日本腦炎
• 麻疹和腮腺炎
• 腦膜炎球菌
• 狂犬病
• 傷寒
• 水痘
• 黃熱病

第 8 章美洲旅行疫苗市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第 9 章亞太旅行疫苗市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第 10 章歐洲、中東和非洲旅行疫苗市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 意大利
• 荷蘭
• 尼日利亞
• 挪威
• 波蘭
• 卡塔爾
• 俄羅斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合酋長國
• 英國

第 11 章競爭態勢

• FPNV定位矩陣
• 市場份額分析：主要公司
• 競爭情景分析：主要公司

第 12 章上市公司名單

第 13 章附錄

• 討論指南
• 關於許可證和價格

The Global Travel Vaccines Market is forecasted to grow significantly, with a projected USD 8,267.01 million in 2023 at a CAGR of 10.04% and expected to reach a staggering USD 16,181.43 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Travel Vaccines Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Travel Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, and Toxoid Vaccines. The Attenuated Vaccines commanded largest market share of 23.23% in 2022, followed by Recombinant Vector Vaccines.

Based on Disease, market is studied across DPT, Hepatitis A, Hepatitis B, Japanese Encephalitis, Measles and Mumps, Meningococcal, Rabies, Typhoid, Varicella, and Yellow Fever. The Hepatitis B commanded largest market share of 11.25% in 2022, followed by Measles and Mumps.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.42% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Travel Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Travel Vaccines Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Travel Vaccines Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Travel Vaccines Market?

4. What is the competitive strategic window for opportunities in the Global Travel Vaccines Market?

5. What are the technology trends and regulatory frameworks in the Global Travel Vaccines Market?

6. What is the market share of the leading vendors in the Global Travel Vaccines Market?

7. What modes and strategic moves are considered suitable for entering the Global Travel Vaccines Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Travel Vaccines Market, by Type, 2022 vs 2030
• 4.3. Travel Vaccines Market, by Disease, 2022 vs 2030
• 4.4. Travel Vaccines Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Popularity of International Tourism
    • 5.1.1.2. Growing Prevalence of Infectious Diseases and Development of Combination Vaccines
    • 5.1.1.3. Recent Investments and Improvement in Cold Chain Storage Infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. Limited Awareness Amongst Travelers
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in Novel Vaccine Technologies and Advancements
    • 5.1.3.2. Government and Organizational Funding and Initiatives for Immunization and Vaccine Development
  • 5.1.4. Challenges
    • 5.1.4.1. Issues Related to Vaccine Handling and Storage
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Travel Vaccines Market, by Type

• 6.1. Introduction
• 6.2. Attenuated Vaccines
• 6.3. Conjugate Vaccines
• 6.4. DNA Vaccines
• 6.5. Inactive Vaccines
• 6.6. Recombinant Vector Vaccines
• 6.7. Subunit Vaccines
• 6.8. Toxoid Vaccines

7. Travel Vaccines Market, by Disease

• 7.1. Introduction
• 7.2. DPT
• 7.3. Hepatitis A
• 7.4. Hepatitis B
• 7.5. Japanese Encephalitis
• 7.6. Measles and Mumps
• 7.7. Meningococcal
• 7.8. Rabies
• 7.9. Typhoid
• 7.10. Varicella
• 7.11. Yellow Fever

8. Americas Travel Vaccines Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Travel Vaccines Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Travel Vaccines Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

1. Abbott Laboratories

2. AstraZeneca PLC

3. Bavarian Nordic A/S

4. Bharat Biotech Ltd.

5. Bio-Manguinhos

6. Bio-Med (P) Limited

7. Biological E Limited

8. Cadila Pharmaceuticals Limited

9. CSL Limited

10. Dano Vaccines & Biologicals Private Limited

11. Dynavax Technologies Corporation

12. Emergent BioSolutions Inc.

13. GlaxoSmithKline PLC

14. Incepta Pharmaceuticals Ltd.

15. Indian Immunologicals Ltd.

16. Johnson & Johnson

17. Merck & Co., Inc.

18. Novartis AG

19. Pfizer Inc.

20. Sanofi S.A.

21. Serum Institute of India Pvt. Ltd.

22. Shenzhen Kangtai Biological Products Co., Ltd.

23. Takeda Pharmaceutical Company Limited

24. Valneva SE

25. Walvax Biotechnology Co., Ltd.

LIST OF FIGURES

• FIGURE 1. TRAVEL VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. TRAVEL VACCINES MARKET SIZE, 2022 VS 2030
• FIGURE 3. TRAVEL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. TRAVEL VACCINES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
• FIGURE 6. TRAVEL VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. TRAVEL VACCINES MARKET DYNAMICS
• FIGURE 8. TRAVEL VACCINES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. TRAVEL VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. TRAVEL VACCINES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. TRAVEL VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. TRAVEL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 13. TRAVEL VACCINES MARKET SIZE, BY DPT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. TRAVEL VACCINES MARKET SIZE, BY HEPATITIS A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. TRAVEL VACCINES MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. TRAVEL VACCINES MARKET SIZE, BY JAPANESE ENCEPHALITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. TRAVEL VACCINES MARKET SIZE, BY MEASLES AND MUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. TRAVEL VACCINES MARKET SIZE, BY MENINGOCOCCAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. TRAVEL VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. TRAVEL VACCINES MARKET SIZE, BY TYPHOID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. TRAVEL VACCINES MARKET SIZE, BY VARICELLA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. TRAVEL VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 42. CHINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CHINA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 44. INDIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. INDIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 46. INDONESIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. INDONESIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 48. JAPAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. JAPAN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 50. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 52. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 54. SINGAPORE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. SINGAPORE TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 56. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 58. TAIWAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. TAIWAN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. THAILAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. THAILAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 62. VIETNAM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. VIETNAM TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 64. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 67. DENMARK TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. DENMARK TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 69. EGYPT TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. EGYPT TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 71. FINLAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. FINLAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 73. FRANCE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. FRANCE TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 75. GERMANY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. GERMANY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 77. ISRAEL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. ISRAEL TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 79. ITALY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ITALY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 83. NIGERIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. NIGERIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 85. NORWAY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. NORWAY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 87. POLAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. POLAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 89. QATAR TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. QATAR TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 91. RUSSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. RUSSIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 93. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 97. SPAIN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SPAIN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 99. SWEDEN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SWEDEN TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 101. SWITZERLAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SWITZERLAND TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. TURKEY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. TURKEY TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 105. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 107. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 109. TRAVEL VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 110. TRAVEL VACCINES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 111. TRAVEL VACCINES MARKET LICENSE & PRICING